News | Heart Valve Technology

August 22, 2017 โ€” LivaNova PLC announced its Perceval sutureless aortic heart valve received approval from the Centers ...

Home August 22, 2017
Home
News | ECG

HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device, developed in response to the global unmet need for effective, low-cost, front-line screening of cardiac disease in both symptomatic and asymptomatic patients. MyoVista measures the heart's energy during each heartbeat using a type of advanced signal processing known as Continuous Wavelet Transform (CWT).

Home August 22, 2017
Home
News | Cybersecurity

The U.S. Department of Health and Human Services (HHS), Office for Civil Rights (OCR) recently launched a revised web tool that puts important information on cybersecurity breaches into the hands of individuals. The tool is designed to empower them to better identify recent breaches of health information and to learn how all breaches of health information are investigated and successfully resolved.

Home August 21, 2017
Home
Technology | Cardiac Resynchronization Therapy Devices (CRT)

Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an MR conditional quadripolar (QP) cardiac resynchronization therapy pacemaker (CRT-P) with MRI (magnetic resonance imaging) AutoDetect technology.

Home August 21, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT) in patients implanted with the Resolute Onyx Drug-Eluting Stent (DES) during percutaneous coronary intervention (PCI). Designed to evaluate clinical DAPT outcomes between two DES for the first time ever, the RESOLUTE ONYX ONE-MONTH DAPT Study intends to help inform DAPT guidelines for newer-generation DES that currently favor bare-metal stents (BMS) for patients with stable ischemic heart disease who might require a shorter dual antiplatelet regimen.

Home August 18, 2017
Home
News | Cardiac Imaging

August 18, 2017 โ€” The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document with ...

Home August 18, 2017
Home
Healthcare cybersecurity concerns have increased dramatically as EMRs and medical devices become more digitally connected.
Feature | Cybersecurity | Dave Fornell

August 17, 2017 โ€” Cybersecurity has become a growing concern in healthcare as patient data, medical systems and ...

Home August 18, 2017
Home
News | Cardiac Imaging

Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge technology to Houston Methodist that is not currently available in the Texas Medical Center. This agreement will provide innovative, world-class medical technology to Houston Methodist Hospital and all of its community hospital facilities.

Home August 17, 2017
Home
News | PACS

ScImage Inc. was recently awarded a new DIN-PACS IV (Digital Imaging Network/Picture Archiving and Communications System) contract by the U.S. government. The contract is potentially valued up to $400 million, and the terms include one five-year base period and one five-year option period.

Home August 16, 2017
Home
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity | Dave Fornell

There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology ...

Home August 16, 2017
Home
News | Stem Cell Therapies

August 16, 2017 โ€” BioCardia Inc. recently announced completion of treatment for the 10-patient roll-in cohort for the ...

Home August 16, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

August 16, 2017 โ€” A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) ...

Home August 16, 2017
Home
CMS considers eliminating cardiac bundled payments.
Feature | Cardiovascular Business | Dave Fornell

August 16, 2017 โ€” The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number of ...

Home August 16, 2017
Home
News | Magnetic Resonance Imaging (MRI)

The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast agents, injected in a patient's veins to brighten tissues in MRI images, accumulate in the brain. More than 300 million doses of such drugs have been administered since their introduction in 1987.

Home August 15, 2017
Home
News | Drug-Eluting Balloons

Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) in July to initiate a pivotal clinical trial of the SurVeil drug-coated balloon (DCB). The randomized trial will evaluate the SurVeil DCB for treatment for peripheral artery disease (PAD) in the upper leg compared to the Medtronic IN.PACT Admiral DCB.

Home August 15, 2017
Home
Subscribe Now